Equities

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc

Actions
  • Price (EUR)320.30
  • Today's Change2.30 / 0.72%
  • Shares traded35.00
  • 1 Year change+128.62%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 16:25 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, cash reserves at Madrigal Pharmaceuticals Inc fell by 231.63m. Cash Flow from Financing totalled 595.12m or -- of revenues. In addition the company used 324.23m for operations while cash used for investing totalled 502.52m.
Cash flow per share-24.98
Price/Cash flow per share--
Book value per share35.64
Tangible book value per share35.42
More ▼

Balance sheet in USDView more

Madrigal Pharmaceuticals Inc has a Debt to Total Capital ratio of 13.09%, a lower figure than the previous year's 515.65%.
Current ratio5.98
Quick ratio5.93
Total debt/total equity0.1507
Total debt/total capital0.1309
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.